Effect of atropine 0.01% on myopia control in children aged 6–13 years during the 2022 lockdown in Shanghai
PurposeTo compare the myopic progression in children treated with 0. 01% atropine and those who discontinued atropine during the 2022-home quarantine in Shanghai.MethodsIn this retrospective study, children aged 6–13 years with follow-up visits before (between January 2022 and February 2022) and aft...
Main Authors: | Manrong Yu, Lingli Jiang, Minjie Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Public Health |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2023.1074272/full |
Similar Items
-
Analysis of Factors That May Affect the Effect of Atropine 0.01% on Myopia Control
by: Xiaoyu Zhang, et al.
Published: (2020-09-01) -
Atropine in the treatment of childhood myopia
by: Sanitha Sathyan
Published: (2019-01-01) -
The Role of Atropine in Preventing Myopia Progression: An Update
by: Alberto Chierigo, et al.
Published: (2022-04-01) -
A Pilot Study on the Efficacy and Safety of 0.01% Atropine in German Schoolchildren with Progressive Myopia
by: Lutz Joachimsen, et al.
Published: (2019-06-01) -
Effects of atropine 0.01% on refractive errors in children with myopia
by: Xingxue Zhu, et al.
Published: (2023-08-01)